Jazz Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 47 Posts
1 2 3
5 Low Price-To-Book Stocks Worth Buying In July
Article By: Zacks Investment Research Monday, July 9, 2018 9:44 PM EDT
A lower P/B compared with the industry average implies that there is enough room for the stock to gain.
In this article: AXL, TPC, WDC, JAZZ, RYAM
Read
5 Excellent Value Stocks Based On Low PEG Ratio
Article By: Zacks Investment Research Wednesday, August 30, 2017 10:43 AM EDT
The popularity of value investing is on the rise. The success of billionaire value investors like Warren Buffett further underscores the fact.
In this article: AET, GTN, JAZZ, UNIT, LNTH
Read
Biotech Digest – JAZZ Reports Positive Results, CTSO Inks New Contract, AMGN Forges Collaboration
Article By: KKD Healthcare Analytics Tuesday, April 25, 2017 10:15 AM EDT
Capricor Therapeutics announced encouraging six-month results in a Phase 1/2 clinical trial. Jazz Pharmaceuticals reported results from its Phase 2/3 clinical trial. Amgen announced its new collaboration with Novartis.
In this article: NVS, EAPH, ACHN, JAZZ, AMGN, CANF, CAPR, CTSO
Read
5 Drug Stocks Poised To Beat Earnings Estimates In Q4
Article By: Arpita Dutt Thursday, February 9, 2017 11:11 AM EDT
A positive earnings picture continues to emerge from the fourth-quarter earnings season with both earnings and revenue growth improving compared to recent quarters.
In this article: EXEL, INCY, JAZZ, IRWD, AKAO
Read
The Band Plays On
Article By: Tim Knight Tuesday, December 6, 2016 1:11 PM EDT
One of my favorite shorts these days is Jazz Pharmaceuticals. I think it’s got a long way to go down from here.
In this article: JAZZ
Read
2 Stocks To Watch After The Market Closes On Election Day
Article By: Leigh Drogen Tuesday, November 8, 2016 9:05 AM EDT
Jazz Pharmaceuticals along with the rest of the healthcare industry have suffered a down year heading into this pivotal election. Shares of Jazz are down nearly 25% in the past 12 months on a string of weaker than expected financial results.
In this article: JAZZ, TRIP Also: EXPE, PCLN, LVS
Read
Shelf Support Failure
Article By: Tim Knight Saturday, November 5, 2016 9:34 AM EDT
Here’s another high-flying firm in Palo Alto that I think is heading for much lower prices, even though it’s lost 50% of its market cap already.
In this article: JAZZ
Read
What's New In The Magic Recipe Spell This Week?
Article By: Steve Alexander Sunday, October 30, 2016 4:27 PM EDT
It's been a rough week for the drug distributors, but they might be worth a look as that industry is a reliable cash-generating one controlled by an oligarchy of just three major players. But they are just a few ousted from our lists this week.
In this article: CAH, CBI, DVA, GBX, JNPR, MCK, SBH, USNA, JAZZ, CHKP, EXPD, GMED
Read
Insider Weekends - Edition 317
Article By: Asif Suria Sunday, July 17, 2016 4:27 PM EDT
As we enter the thick of earnings season, insider buying decreased significantly last week with insiders buying $6.38 million of stock compared to $44.58 million in the week prior. Selling on the other hand increased.
In this article: ATU, DRI, OPK, WES, JAZZ, COST, FB, HQY, RHP, GKOS
Read
5 Attractive Biotechnology Stocks For Healthy Long-Term Returns
Article By: Chuck Carnevale Saturday, June 11, 2016 10:46 AM EDT
The biotechnology sector contains many exciting growth stocks. Consequently, I offer the following 5 biotechnology stocks as attractive looking research candidates primarily for growth or long-term total return.
In this article: JAZZ, AMGN, BIIB, CELG, ABBV
Read
S&P Ends Week Barely Changed Despite Jobs Report Shortfall
Article By: The Fly Sunday, June 5, 2016 12:03 PM EDT
The S&P 500 barely budged from where it began the week despite a slew of macroeconomic events, highlighted at home by the lackluster jobs report for May and abroad by the Japanese delay in its sales tax hike as well as meetings of the ECB and OPEC.
In this article: AGN, CRM, GXP, WR, SFTBF, JAZZ, SQI, ORCL, DWRE, SRPT, CPXX, MKTO Also: DV, KORS, UA, BABA, AMBA, AVGO
Read
Spend More, Buy The Same
Article By: Marvin R Clark Wednesday, June 1, 2016 1:21 AM EDT
As we wrap up the month of May, here’s the tally: The Dow gained 14 points for the month, the S&P 500 gained 29 points, and the Nasdaq was the winner with a gain of 173. The 10-year Treasury was flat. Oil added $3 a barrel. Gold lost $78 an ounce.
In this article: GXP, VZ, WR, FXE, VLKAF, JAZZ, MSFT, OILB, USO, FB, TWTR, GOOGL, CPXX
Read
Biotech Rally Moving Toward April Highs: ASCO And M&A Provides Underlying Support
Article By: Rod Raynovich Wednesday, June 1, 2016 12:03 AM EDT
Biotech stocks are pretty solid over two weeks probably anticipating ASCO news and helped by more M&A news. Since hitting a recent low of $258.90 on May 19 the IBB is up over 8% and 6% over five days to $279.77 yesterday.
In this article: ALNY, ARIA, ARRY, IBB, JAZZ, GILD, XBI, XLV, JUNO, ABBV, KITE, BLUE, CPXX, EDIT
Read
Dow Jones Industrial Average Loses 86 Points On Rising Rate Hike Expectations
Article By: Money Morning Tuesday, May 31, 2016 10:04 PM EDT
The Dow Jones Industrial Average today fell more than 86 points as traders' expectations for a rate hike in June accelerated.
In this article: BRK-A, GXP, MDT, MON, VRX, VZ, WR, BAYRY, JAZZ, AAPL, NFLX, OILB, USO, CPXX
Read
Jazz Pharmaceuticals Posts Q1 Earnings Beat, Updates 2016 Outlook
Article By: Zacks Investment Research Tuesday, May 10, 2016 8:45 PM EDT
Jazz Pharmaceuticals, Inc. released its first quarter fiscal 2016 earnings results, posting earnings of $1.87 per share and revenue of $336 million.
In this article: JAZZ
Read
We’ve Hit Bottom – Here’s How To Make 69% Off The Rebound
Article By: Michael A Robinson Wednesday, February 24, 2016 12:10 PM EDT
The biotech market is already bouncing back. And that means the three plays I’m going to tell you about are poised to hand investors 69% on average…
In this article: JAZZ, CELG
Read
1 to 16 of 47 Posts
1 2 3